Infiltrating breast carcinoma in patients age 30 years and younger: Long term outcome for life, relapse, and second primary tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Infiltrating breast carcinoma in patients age 30 years and younger: Long term outcome for life, relapse, and second primary tumors

Published:1992-01 Issue:5 Volume:23 Page:969-975
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Lee Catherine G.,McCormick Beryl,Mazumdar Madhuchhanda,Vetto John,Borgen Patrick I.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference42 articles.

1. Long-term followup of breast cancer patients: The 30-year report;Adair;Cancer,1974

2. Age as a prognostic factor in breast cancer;Adami;Cancer,1985

3. Carcinoma of the breast in women 30 years of age or less;Birks;Surg. Gynec. Obstet.,1973

4. An analysis of clinical and histopathological features in 101 cases of carcinoma of the breast in women under 35 years of age;Brightmore;Br. J. Cancer,1970

5. Breast cancer: a 21 year experience with conservative surgery and radiation;Clark;Int. J. Radiat. Oncol. Biol. Phys.,1982

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment Outcomes of Stereotactic Ablative Body Radiotherapy on Extra-cranial Oligometastatic and Oligoprogressive Breast Cancer: Mature Results from a Single Institution Experience;Clinical Oncology;2024-06

2. SABR in oligometastatic breast cancer: Current status and future directions;The Breast;2021-12

3. Oligometastases: history and future vision of breast cancer;Translational Cancer Research;2020-08

4. Single‐fraction stereotactic ablative body radiotherapy for sternal metastases in oligometastatic breast cancer: Technique and single institution experience;Journal of Medical Imaging and Radiation Oncology;2020-06-25

5. Stereotactic ablative body radiotherapy (SABR) for bone only oligometastatic breast cancer: A prospective clinical trial;The Breast;2020-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3